Riskpilot← Back to searchSign inGet full accessORKANDA AB
ABActiveOrg 5593071425StockholmWholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
+27% vs 2023
Equity ratio
31.7%
Financial strength
Net profit 2024
SEK -18K
+31% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | +27% |
| Net profit | SEK -18K | +31% |
| Total assets | SEK 41K | -28% |
| Equity | SEK 13K | -7% |
| Employees | 0 | — |
Legal name
ORKANDA AB
Org number
5593071425
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 mars 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten Då minst halva antalet ledamöter och minst halva antalet suppleanter ska vara bosatta inom EES uppfyller bolaget numera inte bosättningskraven.
Company purpose
Företaget ska bedriva verksamhet med tillverkning och försäljning av hissar (handikapp och hem), hjälpmedel, konsultation, public relationer och marknadsföring av samma.
Address
Stockholm
Email
support@orkanda.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | — | −18 | −26 | −19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 0 | −18 | −26 | −19 |
| Net financials | — | — | — | — |
| Profit before tax | 0 | −18 | −26 | −18 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | 0 | −18 | −26 | −18 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 30 | 57 | 41 |
| Equity | 25 | 7 | 14 | 13 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 22 | 43 | 27 |
| Total debt | — | 22 | 43 | 27 |
EBITDA margin
-1900000.0%
This company
15.8%
Market median
-12025416% vs market
20212024
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
20212024
Return on equity
-138.5%
This company
18.4%
Market median
-853% vs market
20212024
Net profit margin
-1800000.0%
This company
8.1%
Market median
-22222322% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
2.15×
This company
0.62×
Market median
-247% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORKANDA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Silvia Strauss | Authorized Recipient of Service | 0 companies |
| Sadiqul Hassan | Deputy Board Member | 0 companies |
| Tarvo Silivask | Board of Directors | 0 companies |
| Edwin Fitra Rully | Board of Directors | 0 companies |